Class information for:
Level 1: OK 432//AEGINETIA INDICA L//PROD LIFECYCLE MED INFORMAT

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
20647 450 27.0 58%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
210 3       IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS 51916
3041 2             PSK//OK 432//IMEXON 2463
20647 1                   OK 432//AEGINETIA INDICA L//PROD LIFECYCLE MED INFORMAT 450

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 OK 432 authKW 2872874 25% 38% 111
2 AEGINETIA INDICA L authKW 339277 1% 100% 5
3 PROD LIFECYCLE MED INFORMAT address 271422 1% 100% 4
4 PROD S address 255756 2% 54% 7
5 OK 432 PICIBANIL authKW 180945 1% 67% 4
6 AEGINETIA INDICA ROXBERT authKW 135711 0% 100% 2
7 DEMETHYLPODOPHYLLOTOXIN authKW 135711 0% 100% 2
8 TH1 TYPE CYTOKINES authKW 108564 1% 40% 4
9 SAPYLIN authKW 90473 0% 67% 2
10 13 CIS RETINOIC ACID 13 CRA authKW 67855 0% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Oncology 3050 43% 0% 193
2 Immunology 2503 36% 0% 163
3 Medicine, Research & Experimental 428 12% 0% 56
4 Pharmacology & Pharmacy 212 15% 0% 67
5 Gastroenterology & Hepatology 58 4% 0% 19
6 Surgery 52 8% 0% 36
7 Medical Laboratory Technology 19 1% 0% 6
8 Otorhinolaryngology 19 2% 0% 8
9 Microbiology 16 4% 0% 18
10 Cell Biology 15 5% 0% 23

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 PROD LIFECYCLE MED INFORMAT 271422 1% 100% 4
2 PROD S 255756 2% 54% 7
3 AFFLICTED HOSP 67855 0% 100% 1
4 HIGASHI KU ABORAT 67855 0% 100% 1
5 INTERNAL MEDBRAIN KOREA 21 PROJECT MED 67855 0% 100% 1
6 LIAOCHENG HOSP 67855 0% 100% 1
7 POST MARKETING CLIN TRIAL 67855 0% 100% 1
8 RADIAT BIOL MARINE 67855 0% 100% 1
9 SHINJUKU KU ADV MED 67855 0% 100% 1
10 STUDY GRP GASTR CANC 67855 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 BIOTHERAPY 33212 3% 4% 12
2 JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE 28760 3% 3% 14
3 CANCER IMMUNOLOGY IMMUNOTHERAPY 21385 8% 1% 37
4 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 16191 5% 1% 22
5 JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS 6814 2% 1% 7
6 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY 5649 1% 3% 3
7 IMMUNOPHARMACOLOGY 4121 2% 1% 9
8 NATURAL IMMUNITY AND CELL GROWTH REGULATION 3909 1% 2% 3
9 GANN 3263 1% 1% 6
10 JOURNAL OF IMMUNOTHERAPY 3254 2% 1% 9

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 OK 432 2872874 25% 38% 111 Search OK+432 Search OK+432
2 AEGINETIA INDICA L 339277 1% 100% 5 Search AEGINETIA+INDICA+L Search AEGINETIA+INDICA+L
3 OK 432 PICIBANIL 180945 1% 67% 4 Search OK+432+PICIBANIL Search OK+432+PICIBANIL
4 AEGINETIA INDICA ROXBERT 135711 0% 100% 2 Search AEGINETIA+INDICA+ROXBERT Search AEGINETIA+INDICA+ROXBERT
5 DEMETHYLPODOPHYLLOTOXIN 135711 0% 100% 2 Search DEMETHYLPODOPHYLLOTOXIN Search DEMETHYLPODOPHYLLOTOXIN
6 TH1 TYPE CYTOKINES 108564 1% 40% 4 Search TH1+TYPE+CYTOKINES Search TH1+TYPE+CYTOKINES
7 SAPYLIN 90473 0% 67% 2 Search SAPYLIN Search SAPYLIN
8 13 CIS RETINOIC ACID 13 CRA 67855 0% 100% 1 Search 13+CIS+RETINOIC+ACID+13+CRA Search 13+CIS+RETINOIC+ACID+13+CRA
9 70 PERCENT HEPATECTOMY 67855 0% 100% 1 Search 70+PERCENT+HEPATECTOMY Search 70+PERCENT+HEPATECTOMY
10 ADRENOCHROME MONOAMINOGUANIDINE METHANESULFONATE 67855 0% 100% 1 Search ADRENOCHROME+MONOAMINOGUANIDINE+METHANESULFONATE Search ADRENOCHROME+MONOAMINOGUANIDINE+METHANESULFONATE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 RYOMA, Y , MORIYA, Y , OKAMOTO, M , KANAYA, I , SAITO, M , SATO, M , (2004) BIOLOGICAL EFFECT OF OK-432 (PICIBANIL) AND POSSIBLE APPLICATION TO DENDRITIC CELL THERAPY.ANTICANCER RESEARCH. VOL. 24. ISSUE 5C. P. 3295-3301 42 66% 22
2 ABEL, U , VOGLER, S , (1992) TREATMENT OF MALIGNANT-TUMORS WITH THE STREPTOCOCCAL PREPARATION OK-432.TUMORDIAGNOSTIK & THERAPIE. VOL. 13. ISSUE 2. P. 43-48 36 86% 0
3 HOSOYA, Y , KOBAYASHI, E , TAKIZAWA, T , FUJIMURA, A , YASUDA, Y , NAGAI, H , KANAZAWA, K , (2005) EFFECT OF INTRAPERITONEAL NEUTROPHILS INDUCED BY OK432 ON MALIGNANT ASCITES.SURGERY TODAY. VOL. 35. ISSUE 1. P. 60-66 26 65% 2
4 TANO, T , OKAMOTO, M , KAN, S , NAKASHIRO, K , SHIMODAIRA, S , YAMASHITA, N , KAWAKAMI, Y , HAMAKAWA, H , (2012) GROWTH INHIBITION AND APOPTOSIS BY AN ACTIVE COMPONENT OF OK-432, A STREPTOCOCCAL AGENT, VIA TOLL-LIKE RECEPTOR 4 IN HUMAN HEAD AND NECK CANCER CELL LINES.ORAL ONCOLOGY. VOL. 48. ISSUE 8. P. 678 -685 21 58% 6
5 OSHIKAWA, T , OKAMOTO, M , TANO, T , SASAI, A , KAN, S , MORIYA, Y , RYOMA, Y , SAITO, M , AKIRA, S , SATO, M , (2006) ANTITUMOR EFFECT OF OK-432-DERIVED DNA - ONE OF THE ACTIVE CONSTITUENTS OF OK-432, A STREPTOCOCCAL IMMUNOTHEROPEUTIC AGENT.JOURNAL OF IMMUNOTHERAPY. VOL. 29. ISSUE 2. P. 143-150 19 58% 13
6 OHE, G , SASAI, A , UCHIDA, D , TAMATANI, T , NAGAI, H , MIYAMOTO, Y , (2013) EFFECT OF SOLUBLE FACTORS DERIVED FROM ORAL CANCER CELLS ON THE PRODUCTION OF INTERFERON-GAMMA FROM PERIPHERAL BLOOD MONONUCLEAR CELLS FOLLOWING STIMULATION WITH OK-432.ONCOLOGY REPORTS. VOL. 30. ISSUE 2. P. 945-951 18 51% 0
7 HOMMA, S , SAGAWA, Y , KOMITA, H , KOIDO, S , NAGASAKI, E , RYOMA, Y , OKAMOTO, M , (2007) MECHANISM OF ANTITUMOR EFFECT ON MOUSE HEPATOCELLULAR CARCINOMA BY INTRATUMORAL INJECTION OF OK-432, A STREPTOCOCCAL PREPARATION.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 56. ISSUE 8. P. 1265-1274 14 74% 8
8 OKAMOTO, M , OSHIKAWA, T , TANO, T , AHMED, SU , KAN, S , SASAI, A , AKASHI, S , MIYAKE, K , MORIYA, Y , RYOMA, Y , ET AL (2006) MECHANISM OF ANTICANCER HOST RESPONSE INDUCED BY OK-432, A STREPTOCOCCAL PREPARATION, MEDIATED BY PHAGOCYTOSIS AND TOLL-LIKE RECEPTOR 4 SIGNALING.JOURNAL OF IMMUNOTHERAPY. VOL. 29. ISSUE 1. P. 78-86 20 50% 39
9 KAGEYAMA, Y , SAKAI, Y , ARAI, G , HYOCHI, N , SUZUKI, M , MASUDA, H , KAWAKAMI, S , HAYASHI, T , OKUNO, T , KOBAYASHI, T , ET AL (2002) INTRACAVITARY ADMINISTRATION OF OK-432 WITH SUBCUTANEOUS PRIMING FOR MALIGNANT ASCITES IN A CASE OF ADVANCED RENAL CELL CARCINOMA.INTERNATIONAL JOURNAL OF UROLOGY. VOL. 9. ISSUE 1. P. 57-59 12 100% 1
10 YAMAGIWA, S , ICHIDA, T , SATO, K , SUGAHARA, S , YONEKURA, K , UCHIDA, M , UEHARA, K , KATOH, M , SATOH, H , ABO, T , ET AL (2000) LIPOSOME-ENCAPSULATED OK-432 SPECIFICALLY AND SUSTAINEDLY INDUCES HEPATIC NATURAL KILLER CELLS AND INTERMEDIATE T CELL RECEPTOR CELLS.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. VOL. 15. ISSUE 5. P. 542-549 18 64% 1

Classes with closest relation at Level 1



Rank Class id link
1 20310 TOXICOL S 216 KASHIMA YODOGAWA KU//NCPP//AMOEBOID NEUTROPHIL
2 18996 PSK//POLYSACCHAROPEPTIDE//POLYSACCHARIDE K
3 28487 ADJUVANT SPECIFIC IMMUNOTHERAPY//CHEMOTACTIC INHIBITORS//CHIMERIC ANTIBODY 311
4 27223 CONTROL INNATE IMMUN//INTEGRATED HOLIST IMMUNOL//ONO 4007
5 11429 CANCER IMMUNOLOGY IMMUNOTHERAPY//ANTITUMOR CYTOTOXIC LYMPHOCYTES//THYMIC IMMUNE REACTIVITY
6 30053 Z 100//BCG VIABILITY//N N DILAURYL CHITOSAN
7 7508 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL
8 34944 DENT ORAL SURG 2 HIGASHI KU//P 53 ASSAY//THYMOCYTES DIFFERENTIATION
9 33447 TULAREMIA LIVE VACCINE//ANTHRAX LIVE VACCINE//HEPATOMA H 2 73
10 1228 CELLULAR IMMUNOLOGY//IMMUNOLOGY//JOURNAL OF IMMUNOLOGY

Go to start page